Treatment with Oral or Inhaled Treprostinil in Patients with Pulmonary Arterial Hypertension and Cardiovascular Comorbidities

By sjmartinez • December 3, 2024

White RJ, El-Kersh K, Rosenkranz S, Franco V, Vizza CD, Badagliacca R, Pepke-Zaba J, Elwing J, Argula RG, Shapiro S, Kim H, Seaman S, Shen E, Das M, Broderick M, McLaughlin V. Treatment with Oral or Inhaled Treprostinil in Patients with Pulmonary Arterial Hypertension and Cardiovascular Comorbidities. Chest. 2024 Nov 30:S0012-3692(24)05604-6. doi: 10.1016/j.chest.2024.11.027. Epub ahead of print. PMID: 39622469.

Tags: cardiac, Cardiology/Epi, comorbidity, Publications, pulmonary arterial hypertension, Treprostinil, Veterans Administration

Symptom status and non-calcified plaque burden across CAC strata: insights from AI-based CCTA quantification

Iskander B, Kambalapalli S, Punnanithinont N, Kinninger A, Krishnan S, Ichikawa K, Lakshmanan S, Roy S, Budoff MJ. Symptom status and non-calcified plaque burden across[...]

Defining the Name of the Game in Exercise Oncology: How Do We Incentivize Physical Activity?

Arega E, Dieli-Conwright CM, Yang EH. Defining the Name of the Game in Exercise Oncology: How Do We Incentivize Physical Activity? JACC CardioOncol. 2025 Dec;7(7):829-832.[...]

Estimating the Proportion of Adverse Pregnancy Outcomes Prevented With Improved Early Pregnancy Cardiovascular Health

Borrowman JD, Huang X, Perak AM, Chung JH, Catov JM, Thelilen LH, Bairey Merz CN, Levine LD, Greenland P, Yee LM, Grobman WA, Khan SS,[...]